arrow
arrow
arrow
arrow
arrow
arrow
arrow
arrow
arrow
arrow
arrow
arrow
arrow
arrow


Home > Medical News > News Releases > Patient Advisory

Patient Advisory

Mercy Medical Center is aware of the situation involving New England Compounding Center (NECC) and the recall of an injectable steroid medication that has been implicated in the outbreak of fungal meningitis and joint infections.

Mercy Medical Center did not receive or use this particular medication from NECC.

As a precaution to insure the safety of our patients, Mercy Medical Center has removed all drugs in our inventory produced by NECC and is participating in any recalls of NECC drugs.

One medication provided by NECC that is not on the list of potentially infected medications was supplied to Mercy Medical Center. Any patient treated at Mercy Medical Center who received this medication has been contacted by both their physician and the hospital. At this time there are no reported issues related to this medication or with patients who received this medication.

At Mercy Medical Center the safety and wellness of patients is our first priority. Please do not hesitate to call us about this matter at 413-748-9000 and ask for the Quality and Risk Management Department.

To learn more about the investigation of products from NECC you may also call the FDAs Division of Drug Information at 855-543-DRUG (3784). Additional information is available at www.cdc.gov/hai/outbreaks/meningitis.html and www.fda.gov/drugs.

For more information please feel free to contact us.


 
Legal Information
Privacy Statement
Website Mission